Evoke Pharma Inc (NASDAQ: EVOK) is -5.71% lower on its value in year-to-date trading and has touched a low of $1.94 and a high of $12.32 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EVOK stock was last observed hovering at around $6.99 in the last trading session, with the day’s loss setting it -0.88%.
Currently trading at $6.11, the stock is 95.57% and 90.38% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.62 million and changing -12.59% at the moment leaves the stock 50.37% off its SMA200. EVOK registered 38.24% gain for a year compared to 6-month loss of 32.83%. The firm has a 50-day simple moving average (SMA 50) of $3.20942 and a 200-day simple moving average (SMA200) of $4.06323.
The stock witnessed a 102.63% gain in the last 1 month and extending the period to 3 months gives it a 195.17%, and is 127.14% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 20.59% over the week and 11.02% over the month.
Evoke Pharma Inc (EVOK) has around 3 employees, a market worth around $9.13M and $11.59M in sales. Fwd P/E is 4.10. Profit margin for the company is -43.80%. Distance from 52-week low is 214.95% and -50.41% from its 52-week high. The company has generated returns on investments over the last 12 months (-85.72%).
The EPS is expected to grow by 64.06% this year
10.0 institutions hold shares in Evoke Pharma Inc (EVOK), with institutional investors hold 16.45% of the company’s shares. The shares outstanding are 1.49M, and float is at 1.41M with Short Float at 1.26%. Institutions hold 16.23% of the Float.
Evoke Pharma Inc (EVOK) Insider Activity
The most recent transaction is an insider sale by Nantahala Capital Management,, the company’s 10% Owner. SEC filings show that Nantahala Capital Management, sold 41 shares of the company’s common stock on Jan 28 ’25 at a price of $4.39 per share for a total of $180.0. Following the sale, the insider now owns 0.15 million shares.
